The translocator protein (18 kDa): central nervous system disease and drug design

J Med Chem. 2009 Feb 12;52(3):581-92. doi: 10.1021/jm8011678.
No abstract available

Publication types

  • Review

MeSH terms

  • Acetamides / pharmacology
  • Apoptosis / physiology
  • Central Nervous System / physiology*
  • Central Nervous System Diseases / drug therapy
  • Central Nervous System Diseases / physiopathology
  • Drug Design
  • Humans
  • Indoleacetic Acids / pharmacology
  • Indoles / pharmacology
  • Mitochondrial Membranes / physiology
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / physiopathology
  • Phenyl Ethers / pharmacology
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Receptors, GABA* / chemistry
  • Receptors, GABA* / drug effects
  • Receptors, GABA* / physiology

Substances

  • Acetamides
  • Indoleacetic Acids
  • Indoles
  • Phenyl Ethers
  • Pyrazoles
  • Pyrimidines
  • Receptors, GABA
  • TSPO protein, human
  • indoleacetamide